Cargando…

Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia

AIM: To examine the optimal absolute lymphocyte count (ALC) cut-off utilizing receiver operator characteristics (ROC) in addition to graft characteristics associated with early ALC recovery. METHODS: Patients who received T-cell replete peripheral hematopoietic cell transplantation (HCT) for acute l...

Descripción completa

Detalles Bibliográficos
Autores principales: Damlaj, Moussab, Ghazi, Samer, Mashaqbeh, Walid, Gmati, Gamal, Salama, Hend, Abuelgasim, Khadega A, Rather, Mushtaq, Hajeer, Ali, Al-Zahrani, Mohsen, Jazieh, Abdul-Rahman, Alhejazi, Ayman, Alaskar, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573899/
https://www.ncbi.nlm.nih.gov/pubmed/28900606
http://dx.doi.org/10.5500/wjt.v7.i4.235
_version_ 1783259733988212736
author Damlaj, Moussab
Ghazi, Samer
Mashaqbeh, Walid
Gmati, Gamal
Salama, Hend
Abuelgasim, Khadega A
Rather, Mushtaq
Hajeer, Ali
Al-Zahrani, Mohsen
Jazieh, Abdul-Rahman
Alhejazi, Ayman
Alaskar, Ahmed
author_facet Damlaj, Moussab
Ghazi, Samer
Mashaqbeh, Walid
Gmati, Gamal
Salama, Hend
Abuelgasim, Khadega A
Rather, Mushtaq
Hajeer, Ali
Al-Zahrani, Mohsen
Jazieh, Abdul-Rahman
Alhejazi, Ayman
Alaskar, Ahmed
author_sort Damlaj, Moussab
collection PubMed
description AIM: To examine the optimal absolute lymphocyte count (ALC) cut-off utilizing receiver operator characteristics (ROC) in addition to graft characteristics associated with early ALC recovery. METHODS: Patients who received T-cell replete peripheral hematopoietic cell transplantation (HCT) for acute leukemia were identified. ALC cut-off was established using ROC analysis and subsequently the cohort was stratified. Time to endpoint analysis and cox regression modelling was computed to analyze outcomes. RESULTS: A total of 72 patients met the inclusion criteria and were analyzed. Optimal ALC cut-off was established to be on day 14 (D14) with ALC > 0.3 × 10(9)/L. At 2 years, cumulative incidence of relapse was 16.9% vs 46.9% (P = 0.025) for early and delayed lymphocyte recovery cohorts, respectively. Chronic graft vs host disease was more prevalent in the early lymphocyte recovery (ELR) group at 70% vs 27%, respectively (P = 0.0006). On multivariable analysis for relapse, ELR retained its prognostic significance with HR = 0.27 (0.05-0.94, P = 0.038). CONCLUSION: ELR is an independent predictor for relapse in patients receiving allogeneic HCT for acute leukemia. ELR was influenced by graft characteristics particularly CD34 count.
format Online
Article
Text
id pubmed-5573899
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-55738992017-09-12 Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia Damlaj, Moussab Ghazi, Samer Mashaqbeh, Walid Gmati, Gamal Salama, Hend Abuelgasim, Khadega A Rather, Mushtaq Hajeer, Ali Al-Zahrani, Mohsen Jazieh, Abdul-Rahman Alhejazi, Ayman Alaskar, Ahmed World J Transplant Observational Study AIM: To examine the optimal absolute lymphocyte count (ALC) cut-off utilizing receiver operator characteristics (ROC) in addition to graft characteristics associated with early ALC recovery. METHODS: Patients who received T-cell replete peripheral hematopoietic cell transplantation (HCT) for acute leukemia were identified. ALC cut-off was established using ROC analysis and subsequently the cohort was stratified. Time to endpoint analysis and cox regression modelling was computed to analyze outcomes. RESULTS: A total of 72 patients met the inclusion criteria and were analyzed. Optimal ALC cut-off was established to be on day 14 (D14) with ALC > 0.3 × 10(9)/L. At 2 years, cumulative incidence of relapse was 16.9% vs 46.9% (P = 0.025) for early and delayed lymphocyte recovery cohorts, respectively. Chronic graft vs host disease was more prevalent in the early lymphocyte recovery (ELR) group at 70% vs 27%, respectively (P = 0.0006). On multivariable analysis for relapse, ELR retained its prognostic significance with HR = 0.27 (0.05-0.94, P = 0.038). CONCLUSION: ELR is an independent predictor for relapse in patients receiving allogeneic HCT for acute leukemia. ELR was influenced by graft characteristics particularly CD34 count. Baishideng Publishing Group Inc 2017-08-24 2017-08-24 /pmc/articles/PMC5573899/ /pubmed/28900606 http://dx.doi.org/10.5500/wjt.v7.i4.235 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Observational Study
Damlaj, Moussab
Ghazi, Samer
Mashaqbeh, Walid
Gmati, Gamal
Salama, Hend
Abuelgasim, Khadega A
Rather, Mushtaq
Hajeer, Ali
Al-Zahrani, Mohsen
Jazieh, Abdul-Rahman
Alhejazi, Ayman
Alaskar, Ahmed
Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
title Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
title_full Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
title_fullStr Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
title_full_unstemmed Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
title_short Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
title_sort lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573899/
https://www.ncbi.nlm.nih.gov/pubmed/28900606
http://dx.doi.org/10.5500/wjt.v7.i4.235
work_keys_str_mv AT damlajmoussab lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT ghazisamer lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT mashaqbehwalid lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT gmatigamal lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT salamahend lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT abuelgasimkhadegaa lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT rathermushtaq lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT hajeerali lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT alzahranimohsen lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT jaziehabdulrahman lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT alhejaziayman lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia
AT alaskarahmed lymphocyterecoveryisanindependentpredictorofrelapseinallogeneichematopoieticcelltransplantationrecipientsforacuteleukemia